Use of a steroid prodrug for the treatment of disease of the posterior segment of the eye

Details for Australian Patent Application No. 2007267079 (hide)

Owner Novagali Pharma SA

Inventors Lambert, Gregory; Rabinovich-Guilatt, Laura

Agent Wrays

Pub. Number AU-A-2007267079

PCT Pub. Number WO2007/138113

Priority 11/444,337 01.06.06 US; 06290902.3 01.06.06 EP

Filing date 1 June 2007

Wipo publication date 6 December 2007

International Classifications

A61K 31/573 (2006.01)

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 27/00 (1970.01) Drugs for disorders of the senses

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/138113 Priority application(s): WO2007/138113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267082-Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown

2007267075-Lime glass batch composition